Latest Diabetic retinopathy Stories
ACE2, a molecule that has been shown to prevent damage in the heart, is now proving to be protective of the major organs that are often damaged in diabetic patients.
Research carried out at the Peninsula College of Medicine and Dentistry (PCMD), University of Exeter, has concluded that it would be a safe and cost-effective strategy to screen people with type 2 diabetes who have not yet developed diabetic retinopathy, for the disease once every two years instead of annually.
There may be new found hope for patients whose vision is threatened when medicine injected directly into the eyes fails to cause abnormal blood vessels to recede.
Mark your calendars: May is Healthy Vision Month. Since 2003, the National Eye Institute (NEI) has promoted May with this national eye health observance. During Health Vision Month, NEI hopes to increase awareness about early diagnosis and treatment of vision loss.
A randomized controlled trial involving patients with persistent clinically significant diabetic macular edema (swelling of the retina) suggests the greater efficacy of bevacizumab compared with macular laser therapy that was previously demonstrated at 12 months was maintained through 24 months.
- The parings of haberdine; also, any kind of fragments.